Locations:
Search IconSearch

Tricuspid Valve Reconstruction for Infective Endocarditis: Operative Highlights (Video)

Making use of autologous pericardium when options, and reconstruction references, are few

There are no easy solutions for acute infective tricuspid valve endocarditis in IV drug users, as the risk of prosthetic endocarditis in this population is high. Complete valve resection without replacement is feasible but leads to progressive right-sided heart failure. Reconstruction of the tricuspid valve with autologous pericardium is an alternative option, as demonstrated in the video case study below.

Advertisement

Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy

A 29-year-old female drug abuser with fever, hemoptysis and MRSA bacteremia was started on IV antibiotics. She looked frail and had prominent jugular venous pressure as well as 95 percent saturation on 2 liters of nasal cannula oxygen. She was not on inotropes and had a pulmonary artery pressure of 40/20 mmHg with a good cardiac index. Chest CT showed a large left pleural effusion with associated atelectasis of the left lung. The right lung had manifestations of septic emboli and a smaller pleural effusion.

A Cleveland Clinic surgical team led by cardiothoracic surgeon Faisal Bakaeen, MD, proceeded to excise the patient’s extensive infected and devitalized tissue around the tricuspid valve, leaving only a portion of the anterior leaflet to serve as a reference for reconstruction using autologous pericardium. Dr. Bakaeen walks us through the essential surgical steps — and their underlying rationale — in the narrated operative video below.

Advertisement

Related Articles

operating room during robotic lung transplant surgery

Successful First Case Launches Cleveland Clinic’s Robotic Lung Transplant Program

Procedure places the center among only a handful worldwide to offer the minimally invasive approach

stylized illustration of cholesterol particle floating in bloodstream

Novel siRNA Produces Deep, Durable Reduction in Lp(a)

Phase 1 trial shows up to 97% decrease through 48 weeks with good tolerability

converging lines on a graph pointing downward

Oxidized Phospholipids Track Closely With Lp(a) Reductions in Clinical Trial

Post hoc ALPACA analysis boosts biological rationale for ongoing outcomes trial of lepodisiran

sight picture overlaid on DNA double helix

Positive Effects of CRISPR-Cas9 Gene Editing for Dyslipidemia Endure Through 1 Year

Durability findings propel potential one-time treatment approach to phase 1b testing

Doctor examining patient's heart with a stethoscope

New Guideline Calls on Cardiologists to Think Beyond Silos When Managing CKM Syndrome

Practical takeaways for the reality of overlapping cardiovascular, kidney and metabolic disease

illustration showing device inserted into heart chambers via blood vessels

IMPACT Trial Supports Safety, Feasibility of Preemptive LV Unloading in High-Risk Cardiac Surgery

First prospective study shows early extubation and low vasoactive/inotropic medication use

Dilated aorta

Reassessing Surgical Thresholds in Ascending Aortic Dilation

Height-indexed aortic measurements may better identify risk than diameter alone

gloved hands holding a human heart with podcast overlay

Heart Transplant: Initial Postoperative Care and Where the Field Is Heading (Podcast)

Insights from an expert cardiologist and a transplant surgeon

Ad